Zum Hauptinhalt springen

NAS - Neonatales Abstinenzsyndrom

06. Januar 2023 | NAS - Neonatales Abstinenzsyndrom

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modali

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline…

06. Januar 2023 | NAS - Neonatales Abstinenzsyndrom

Association of medication-assisted treatment and short acting opioids with newborn head circumference and birth weight.

Association of medication-assisted treatment and short acting opioids with newborn head circumference and birth weight. Cutler, A.J., Cox, D.F., Gabrielson, S.M.B. et al. J Perinatol (2022). doi.org/10.1038/s41372-022-01579-z Abst…

06. Januar 2023 | NAS - Neonatales Abstinenzsyndrom

Understanding the effects of opioids vs non-opioids in the treatment of neonatal abstinence syndrome, an in vitro model.

Understanding the effects of opioids vs non-opioids in the treatment of neonatal abstinence syndrome, an in vitro model. Sithisarn T, Legan SJ, Westgate PM, Bada HS, Wilson ME. Front Pediatr. 2022 Nov 22;10:1068330. doi: 10.3389/fped.2…

06. Januar 2023 | NAS - Neonatales Abstinenzsyndrom

Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study.

Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study. Plouffe R, Grywacheski V, Luo W, Nelson C, Orpana H. Can J Public Health. 2022 Dec 8:1–10. doi: 10.17269/s41997-022-00726-5. Epub ahead of print. PMID: 36482…

06. Januar 2023 | NAS - Neonatales Abstinenzsyndrom

Behavioral Outcomes of Children With In-Utero Opioid Exposure Age 2-7 and Parenting Self-Efficacy.

Behavioral Outcomes of Children With In-Utero Opioid Exposure Age 2-7 and Parenting Self-Efficacy. Arter S, Kiel E, McAllister J, Hay MC. J Am Psychiatr Nurses Assoc. 2022 Dec 7:10783903221139840. doi: 10.1177/10783903221139840. Epub a…

11. Dezember 2022 | NAS - Neonatales Abstinenzsyndrom

Quality Improvement Targeting Non-pharmacologic Care and As-needed Morphine Improves Outcomes in Neonatal Abstinence Syndrome.

Quality Improvement Targeting Non-pharmacologic Care and As-needed Morphine Improves Outcomes in Neonatal Abstinence Syndrome. McMorrow TJ, Byrnes K, Gates M, Hairston T, Jawed A, Keydash M, Steele SU, Thorndike D, van Londen L, Bodnar BE.&nb…

11. Dezember 2022 | NAS - Neonatales Abstinenzsyndrom

A Preliminary Assessment of the Effects of Pharmacist-Driven Methadone Stewardship for the Treatment of Neonatal Abstinence Syndrome at a Tertiary Children's Hospital.

A Preliminary Assessment of the Effects of Pharmacist-Driven Methadone Stewardship for the Treatment of Neonatal Abstinence Syndrome at a Tertiary Children's Hospital. Celestin G, Balding M, Para JL, Utley A, Shaddix BP. J Pediatr Phar…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten